Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Acute pulmonary embolism resulting in death; COVID positivity; This is a spontaneous report received from a contactable physician downloaded from the regulatory authority. The regulatory authority report number is BE-FAMHP-DHH-N2021-87195. An 81-years-old male patient received first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 01Apr2021 (Lot Number: ER9480) as single dose for COVID-19 vaccination. Medical history included COPD, hypertension and obesity. Concomitant medication(s) included metoprolol; amlodipine besilate, perindopril arginine (COVERAM); fluticasone propionate, salmeterol xinafoate (SERETIDE); tiotropium bromide (SPIRIVA HANDIHALER); lormetazepam. The patient experienced acute pulmonary embolism resulting in death on 02Apr2021. There was no treatment. After death COVID positivity determined (Apr2021). The patient died on 02Apr2021. An autopsy was performed and results were not provided. The outcome of COVID positivity was unknown. Reporter''s comments: Treatment - No Evolution of the ADR - Deceased Examinations - autopsy performed After death COVID positivity determined No follow-up attempts possible. No further information expected. Reported Cause(s) of Death: acute pulmonary embolism
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166